| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.1 |